|
||||||
| RESPeRATE is the only FDA-cleared, non-drug, medical device clinically proven to lower high blood pressure with no side effects. | ||||||
| RESPeRATE
utilizes a patented technology to deliver certain kinds of breathing
exercises. When these exercises are performed for as little
as 15 minutes a day, 3-4 times a week they have been shown to
significantly lower blood pressure with no side effects.
These therapeutic breathing exercises are difficult to effectively perform without the interactive, personalized coaching that RESPeRATE provides. Proven to Work RESPeRATE has been written about in many leading medical journals, magazines, and books, including the American Heart Association's, "Hypertension Primer" and the Mayo Clinic's, "On High Blood Pressure". RESPeRATE's therapeutic benefit was validated in six separate clinical studies, delivering an average reduction of 14/9. Thousands of patients are using and witnessing the benefits of RESPeRATE
RESPeRATE utilizes a patented technology to pace your breathing from the normal range of 14 to 19 breaths per minute to the "therapeutic zone" of under 10 breaths per minute. Within a few minutes into the exercise the muscles surrounding the small blood vessels dilate [relax], thereby allowing blood to flow more freely, resulting in lower blood pressure. The RESPeRATE's pacing technology, enables you to perform these therapeutic breathing maneuvers effortlessly. Your breathing returns to normal after each session but the beneficial impact on your blood pressure accumulates.
Clinical Studies A Strong Medical & Scientific Foundation Guided by a world-renowned Scientific Advisory Board, InterCure, the maker of RESPeRATE, is committed to evidence-based medicine, clinical validation and a sound scientific foundation. The Company has already demonstrated strong clinical validation for RESPeRATE. Clinical achievements for RESPeRATE, our non-drug medical device for lowering blood pressure, include: The first and only medical device indicated for the adjunctive treatment of hypertension. 14/9 mmHg average sustained blood pressure reductions within 8 weeks. No side effects, no drug interactions. Results of six clinical trials were published in peer-reviewed medical journals. [1-5] . References: [1] Schein M, Gavish B, Herz M et al. "Treating hypertension with a device that slows and regularizes breathing: a randomized double-blind controlled study." J Human Hyperten 2001; 15(4): 271 - 278. [2] Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B "Breathing-control lowers blood pressure." J Human Hyperten 2001; 15(4): 263 - 269. [3] Rosenthal T, Alter A, Peleg E, Gavish B. "Device-guided breathing exercises reduce blood pressure and ambulatory and home measurement." Am J Hyperten 2001; 14(1): 74 - 76. [4] Giannattasio C, Failla M, Meles E, Gentile G, Grappiolo A and Mancia G “Efficacy of self treatment of hypertension at home with device-guided breathing.” Am J Hyperten 2002; 15(4,2)186A. [5] Elliott W, Izzo J, Rosing D, Snyder C, White W, Alter A, Gavish B, and Black B “Hypertension reduction by device-guided breathing shows a dose-response relationship.” Am J Hyperten 2002; 15(4,2)186A. Pricing is as follows:
|
